Expression of cathepsins B and S in the progression of prostate carcinoma.
about
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerProstate cancer relevant antigens and enzymes for targeted drug deliveryAnalysis of a truncated form of cathepsin H in human prostate tumor cellsSynergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancerCathepsin S silencing induces apoptosis of human hepatocellular carcinoma cellsUnderstanding the interaction of an antitumoral platinum(II) 7-azaindolate complex with proteins and DNA.The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyAutophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells.Protease-activated drug development.Cysteine cathepsins in human cancer.Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin BMuscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinomaCathepsin B inhibition limits bone metastasis in breast cancer.Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors.Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways.Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.Cathepsin B: multiple roles in cancer.Cathepsin S: therapeutic, diagnostic, and prognostic potential.V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.Cathepsins in digestive cancers.A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.Cathepsin B: Basis Sequence: Mouse.Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.The clinical significance of cathepsin S expression in human astrocytomas.Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer.Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization.Z-FL-COCHO, a cathepsin S inhibitor, enhances oxaliplatin-mediated apoptosis through the induction of endoplasmic reticulum stress
P2860
Q24807354-7D726867-6C67-4271-B010-5515F3C52DE5Q27013843-889293D8-D46C-4D21-BCE6-5027111F899EQ28215805-64EC3FA6-B182-428A-AB23-BCDF6B3E61A8Q33664639-176ED9BB-FE92-4851-A312-001D8388BA88Q34415646-95CF0A27-3308-4594-9CDE-AD61F9F3169EQ34735358-9C892EAC-0158-4844-9956-E9D93D1A6681Q35052823-E47FBAFF-5DB6-4862-A58B-2544F03C4A17Q35137800-0BB7905D-E5D2-4914-B8AF-986B5178964DQ35222016-7D6F182A-4BCA-42F3-9809-2AB6D266550EQ35623073-8379419E-98D9-4227-B057-5D015C2A8AA1Q35647588-12ECA9F6-02B5-49FB-BF73-55E58B398A80Q35811508-4F9145E8-A86B-4FF8-B9B0-8BD6312AE295Q35970409-B46FA9DF-D330-4C50-9CCD-774CA8D2A001Q36063053-634AA970-2DCD-49D7-92B2-6DCF507303FDQ36276616-FF5DAC4E-E75A-4CDB-89FE-ECEE63774B6DQ36502706-CE5D5D2D-A6E6-43EB-9C39-D03B618DB676Q36511851-FECD9E44-4825-43A3-8730-CEB38382885EQ37057070-EB280B75-EE1C-47D7-9B70-EE1BFD15F1FFQ37076480-EEE0877F-8798-4BC8-832F-300F3C3D47B7Q37317502-DCAED95F-7110-4952-A6F8-C4D166550F88Q37353288-7D37EF42-34E3-4426-AD37-A49E2C9C44D5Q37715063-F4B6097D-F741-4FC0-8950-4D8E2D8D25E9Q38106640-3D910588-F218-4F95-8401-5950F9206C64Q38200056-677620BA-47D2-489E-A415-226B5445CD60Q38420668-25F3F301-CE41-4B2D-A27C-864144FF7696Q39069422-6031B6A1-C447-40D8-B9BD-1A49BBBC0E91Q39237735-7D2C6B88-B803-4C4F-BEB0-740ED3D4249DQ40430939-742716EB-0FD2-45DB-9696-95B9038AC0F5Q40476596-6CBD36F0-5E08-43C5-99CE-EA1303067EB7Q41230243-42F185EB-A10B-486D-8ACB-B6F99B263EFAQ42462220-6DD47590-211D-460E-AB6B-883ABC34092DQ42792431-D7002C32-510C-4D02-A7DE-380F0DD781E2Q44219922-924C8652-24B6-47C9-B604-EBA09184BAD6Q44519638-2BE8E7A3-8052-475D-AD51-1B791615FB0AQ47160270-D2B4451C-0D83-4ABC-924E-04F4E04983D5Q48262713-339BB444-A530-4C68-8A8B-09108A8A919AQ53109387-B72567FD-92FC-45E1-9CB5-48AB44528932Q58771027-2AA52905-DD81-4B70-96E4-107C5D732235
P2860
Expression of cathepsins B and S in the progression of prostate carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression of cathepsins B and S in the progression of prostate carcinoma.
@ast
Expression of cathepsins B and S in the progression of prostate carcinoma.
@en
type
label
Expression of cathepsins B and S in the progression of prostate carcinoma.
@ast
Expression of cathepsins B and S in the progression of prostate carcinoma.
@en
prefLabel
Expression of cathepsins B and S in the progression of prostate carcinoma.
@ast
Expression of cathepsins B and S in the progression of prostate carcinoma.
@en
P2093
P2860
P1476
Expression of cathepsins B and S in the progression of prostate carcinoma.
@en
P2093
B F Sloane
E Fernández
H A Chapman
P L Fernández
P2860
P356
10.1002/1097-0215(20010120)95:1<51::AID-IJC1009>3.0.CO;2-J
P577
2001-01-01T00:00:00Z